sable bio

About:

Sable Bio employs artificial intelligence to analyze large amounts of biomedical data in order to test possible drugs for toxicity.

Website: https://sablebio.com

Top Investors: Seedcamp, Episode 1, Siddhant Jayakumar

Description:

Sable Bio employs artificial intelligence to analyze large amounts of biomedical data to test possible drugs for toxicity. The data is then sent to drug developers to help them make safety judgments.

Total Funding Amount:

1.5M GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2023-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-02-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai